These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3887389)

  • 1. Impaired fibrinolysis after kidney transplantation.
    Seitz R; Michalik R; Egbring R; Karges HE; Lange H
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():941-4. PubMed ID: 3887389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fibrinolysis and protein C increase after cadaver kidney transplantation.
    Seitz R; Michalik R; Karges HE; Lange H; Egbring R
    Thromb Res; 1986 May; 42(3):277-88. PubMed ID: 2424120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators.
    Raasveld MH; Hack CE; ten Berge IJ
    Thromb Haemost; 1992 Sep; 68(3):264-7. PubMed ID: 1279831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of anterior chamber fibrinolysis.
    O'Rourke J; Moore M; Kreutzer DL
    Curr Eye Res; 1985 May; 4(5):569-78. PubMed ID: 2410195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity in dogs after surgically induced trauma.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1137-40. PubMed ID: 8836363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A history of early stent thrombosis is associated with prolonged clot lysis time.
    Pankiw-Bembenek O; Zalewski J; Goralczyk T; Undas A
    Thromb Haemost; 2012 Mar; 107(3):513-20. PubMed ID: 22274545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of the kallikrein-kinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection.
    Schrader J; Gallimore MJ; Eisenhauer T; Isemer FE; Schoel G; Warneke G; Brüggemann M; Scheler F
    Nephron; 1988; 48(3):183-9. PubMed ID: 3281044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of fibrinolysis during labour with and without aprotinin application].
    Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
    Kamper EF; Kopeikina LT; Koutsoukos V; Stavridis J
    J Rheumatol; 1997 Feb; 24(2):262-8. PubMed ID: 9034981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1988; 101():250-6. PubMed ID: 2480017
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys.
    Wang Y; Thompson EM; Whawell SA; Fleming KA
    J Pathol; 1993 Apr; 169(4):445-50. PubMed ID: 8501542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.